CDT 254 Pill - white round, 10mm
Pill with imprint CDT 254 is White, Round and has been identified as Amlodipine Besylate and Atorvastatin Calcium 2.5 mg / 40 mg. It is supplied by Mylan Pharmaceuticals Inc.
Amlodipine/atorvastatin is used in the treatment of High Cholesterol; Angina; Coronary Artery Disease; High Blood Pressure; Prevention of Cardiovascular Disease and belongs to the drug classes antihyperlipidemic combinations, miscellaneous antihypertensive combinations. Not for use in pregnancy. Amlodipine/atorvastatin 2.5 mg / 40 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CDT 254
Amlodipine Besylate and Atorvastatin Calcium
- Imprint
- CDT 254
- Strength
- 2.5 mg / 40 mg
- Color
- White
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Antihyperlipidemic combinations, Miscellaneous antihypertensive combinations
- Pregnancy Category
- X - Not for use in pregnancy
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
calcium carbonate,
croscarmellose sodium,
microcrystalline cellulose,
polysorbate 80,
hydroxypropyl cellulose,
water,
silicon dioxide,
magnesium stearate,
polyvinyl alcohol,
titanium dioxide,
polyethylene glycol 3000,
magnesium silicate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00378-6163 (Discontinued) | Mylan Pharmaceuticals Inc. |
| 63304-0503 (Discontinued) | Ranbaxy Pharmaceuticals Inc. |
| 59762-6712 (Discontinued) | Viatris |
Related images for "CDT 254"
More about amlodipine / atorvastatin
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (6)
- Drug images
- Latest FDA alerts (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antihyperlipidemic combinations
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
